Extensive extraosseous localization of bone imaging agent in a patient with renal failure and rhabdomyolysis accompanied by combined hypercalcemia and hyperphosphatemia.
Four sequential Tc-99m pyrophosphate (PYP) imaging studies were performed in a 28-year-old man with high fever and exudate pharyngitis associated with renal failure. Radiotracer localization in the left ventricle (LV), lungs, kidneys, and skeletal muscles were seen in two, initial imaging studies. In the second and third imaging studies, area of increase in activity was seen in the left-sided bowel. In studies done two months later (in the third study), the radioactivity in the skeletal muscles was no longer seen. Studies obtained nine months (in the fourth study) after the first imaging showed less radiotracer localization in the LV, lungs, and kidneys as compared to that seen in the initial study. Myocardial necrosis and microcalcification were proved by LV biopsy. The exact mechanism of extraosseous bone-imaging agent localization is unknown. However, this phenomenon may be related to renal failure, rhabdomyolysis, hypercalcemia, hyperphosphatemia, or elevated parathyroid hormone. The Tc-99m PYP imaging study is useful and sensitive in the detection of extraosseous tissue calcification and monitoring of the disease process.
Shih
W J
WJ
Nuclear Medicine Division, Veterans Administration, Lexington, Kentucky.
Flueck
J
J
O'Connor
W
W
Domstad
P A
PA
D058186:Acute Kidney Injury / Q000000981:diagnostic imaging* / Q000378:metabolism; D000328:Adult; D011756:Diphosphates / Q000378:metabolism; D006801:Humans; D006934:Hypercalcemia / Q000000981:diagnostic imaging* / Q000378:metabolism; D008297:Male; D010710:Phosphates / Q000097:blood*; D011877:Radionuclide Imaging; D012206:Rhabdomyolysis / Q000000981:diagnostic imaging* / Q000378:metabolism; D013667:Technetium / Q000378:metabolism; D016698:Technetium Tc 99m Pyrophosphate
D011756:Diphosphates; D010710:Phosphates; D016698:Technetium Tc 99m Pyrophosphate; D013667:Technetium